Nestle (NSRGY) is upgraded to Buy as new CEO drives cost cuts and cultural change. Here is what investors need to be know ...
A second blood test has been been approved by the US Food and Drug Administration to assist in diagnosing Alzheimer’s disease ...
The 30 Day SEC Yield is 5.32% (with waivers), despite a progressive. Such a low level of duration implies protection from ...
Every options trader knows that volatility creates both risk and opportunity, but few truly understand the hidden forces that ...
Fintel reports that on October 15, 2025, Goldman Sachs downgraded their outlook for MediaAlpha (NYSE:MAX) from Buy to Neutral ...
Onwuchekwa, U. and Okoronkwo, N. (2025) Knowledge and Practice of Nurses in a Teaching Hospital towards Causes, Treatment ...